| |
Description
Non-Steroidal Anti-Inflammatory (NSAID) drug of the oxicam class. Each mL of this sterile product for injection contains meloxicam 5.0 mg, alcohol 15%, glycofurol 10%, poloxamer 188 5%, sodium chloride 0.8%, glycine 0.5% and meglumine 0.3%, in water for injection, pH adjusted with sodium hydroxide and hydrochloric acid.
Features
Flexible administration either IV or Sub Q.
- Smooth syringability.
- Convenient storage.
Benefits
- Solution for injection can be administered either IV or Sub Q to initiate quick relief of OA while in the clinic.
- The aqueous solution for injection can be quickly and easily drawn into a syringe through small gauge needles (even as small as 25 gauge).
- No refrigeration necessary.
Dosage & Administration
Metacam 5 mg/mL Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by Metacam Oral Suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth. See package insert for complete dosage information.
Precautions
Safe use in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated. Safety has not been established for IM administration.
As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with Metacam, then monitored regularly while on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely. See package insert for complete information.
Uses
Metacam 5 mg/mL Solution for Injection for the control of pain and inflammation associated with osteoarthritis in dogs.
Warning
For injectable use in dogs only.
As with any NSAID all dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to, and periodically during, use of any NSAID. Owners should be advised to observe their dogs for signs of potential drug toxicity.
For IV or Sub-Q injectable use in dogs.
Not for use in humans.
Keep this and all medications out of reach of children. Consult a physician in case of accidental injection by humans.
Highlights
- Long-term safety.
- Flexible administration (IV or Sub-Q).
- Peak blood levels within 2-3 hours.
- Used safely worldwide for more than 7 years.
|
|
